Activatory FcγR expression was observed on tumor-infiltrating CD56+CD3− NK cells, CD11b+CD14+HLA−DR+ monocyte/macrophages (Mo/MΦs), and CD11b+CD15+CD14− granulocytes. This evidence concerns the gene FCGR2A and neoplasm.